Lista de obras - Penny Moore - Dominio Público Uruguay

4E10-resistant variants in a human immunodeficiency virus type 1 subtype C-infected individual with an anti-membrane-proximal external region-neutralizing antibody response

artículo científico publicado en 2007

A comparative immunogenicity study of HIV-1 virus-like particles bearing various forms of envelope proteins, particles bearing no envelope and soluble monomeric gp120.

artículo científico publicado en 2007

Ability to develop broadly neutralizing HIV-1 antibodies is not restricted by the germline Ig gene repertoire

artículo científico publicado en 2015

Antibody specificities associated with neutralization breadth in plasma from human immunodeficiency virus type 1 subtype C-infected blood donors

artículo científico publicado en 2009

Assessing the safety and pharmacokinetics of the anti-HIV monoclonal antibody CAP256V2LS alone and in combination with VRC07-523LS and PGT121 in South African women: study protocol for the first-in-human CAPRISA 012B phase I clinical trial

scientific article published on 26 November 2020

Author Correction: T cell responses to SARS-CoV-2 spike cross-recognize Omicron

artículo científico publicado en 2022

Binding of the mannose-specific lectin, griffithsin, to HIV-1 gp120 exposes the CD4-binding site

artículo científico publicado en 2011

Broad neutralization of human immunodeficiency virus type 1 mediated by plasma antibodies against the gp41 membrane proximal external region

artículo científico publicado en 2009

Broadly neutralizing antibodies targeting the HIV-1 envelope V2 apex confer protection against a clade C SHIV challenge

artículo científico publicado en 2017

Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design

artículo científico publicado en 2013

Cooperation between Strain-Specific and Broadly Neutralizing Responses Limited Viral Escape and Prolonged the Exposure of the Broadly Neutralizing Epitope

artículo científico publicado en 2017

Correction for Anthony et al., "Cooperation between Strain-Specific and Broadly Neutralizing Responses Limited Viral Escape and Prolonged the Exposure of the Broadly Neutralizing Epitope".

artículo científico publicado en 2018

Correction: Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization

artículo científico publicado en 2017

Development of broadly neutralizing antibodies from autologous neutralizing antibody responses in HIV infection

artículo científico publicado en 2014

Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers

article

Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies

artículo científico publicado en 2014

Differences in HIV type 1 neutralization breadth in 2 geographically distinct cohorts in Africa

artículo científico publicado en 2014

Effect of HIV Envelope Vaccination on the Subsequent Antibody Response to HIV Infection

scientific article published on 29 January 2020

Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant

scholarly article by Andrew Pollard published in 2021

Emergence and phenotypic characterization of the global SARS-CoV-2 C.1.2 lineage

artículo científico publicado en 2022

Evidence for both Intermittent and Persistent Compartmentalization of HIV-1 in the Female Genital Tract

scientific article published on 01 May 2019

Evolution of an HIV glycan-dependent broadly neutralizing antibody epitope through immune escape

artículo científico publicado en 2012

Extensive purifying selection acting on synonymous sites in HIV-1 Group M sequences

scientific article published on 23 December 2008

Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization

artículo científico publicado en 2016

Frequency, kinetics and determinants of viable SARS-CoV-2 in bioaerosols from ambulatory COVID-19 patients infected with the Beta, Delta or Omicron variants

artículo científico publicado en 2024

Functional and genetic analysis of coreceptor usage by dualtropic HIV-1 subtype C isolates

artículo científico publicado en 2009

Genetic characteristics of HIV-1 subtype C envelopes inducing cross-neutralizing antibodies

artículo científico publicado en 2007

Genotypic and phenotypic characterization of viral isolates from HIV-1 subtype C-infected children with slow and rapid disease progression

artículo científico publicado en 2006

HIV Superinfection Drives De Novo Antibody Responses and Not Neutralization Breadth

article

HIV broadly neutralizing antibody targets

artículo científico publicado en 2015

HIV-1 Subtype C-Infected Children with Exceptional Neutralization Breadth Exhibit Polyclonal Responses Targeting Known Epitopes

article

High titer HIV-1 V3-specific antibodies with broad reactivity but low neutralizing potency in acute infection and following vaccination

artículo científico publicado en 2009

High-Frequency, Functional HIV-Specific T-Follicular Helper and Regulatory Cells Are Present Within Germinal Centers in Children but Not Adults

article

Identification of broadly neutralizing antibody epitopes in the HIV-1 envelope glycoprotein using evolutionary models

artículo científico publicado en 2013

IgG3 enhances neutralization potency and Fc effector function of an HIV V2-specific broadly neutralizing antibody

scientific article published on 16 December 2019

In vitro generation of HIV type 1 subtype C isolates resistant to enfuvirtide

artículo científico publicado en 2005

Inhibition of HIV Env binding to cellular receptors by monoclonal antibody 2G12 as probed by Fc-tagged gp120.

artículo científico publicado en 2006

Isolation of a monoclonal antibody that targets the alpha-2 helix of gp120 and represents the initial autologous neutralizing-antibody response in an HIV-1 subtype C-infected individual

artículo científico publicado en 2011

Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection

artículo científico publicado en 2009

Mannose-rich glycosylation patterns on HIV-1 subtype C gp120 and sensitivity to the lectins, Griffithsin, Cyanovirin-N and Scytovirin

artículo científico publicado en 2010

Mechanisms of HIV-1 subtype C resistance to GRFT, CV-N and SVN.

artículo científico publicado en 2013

Multiple pathways of escape from HIV broadly cross-neutralizing V2-dependent antibodies

artículo científico publicado en 2013

N-linked glycan modifications in gp120 of human immunodeficiency virus type 1 subtype C render partial sensitivity to 2G12 antibody neutralization

artículo científico publicado en 2007

Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1.

artículo científico publicado en 2006

Neutralization Breadth and Potency of Single-Chain Variable Fragments Derived from Broadly Neutralizing Antibodies Targeting Multiple Epitopes on the HIV-1 Envelope

artículo científico publicado en 2020

New Member of the V1V2-Directed CAP256-VRC26 Lineage That Shows Increased Breadth and Exceptional Potency

artículo científico publicado en 2015

Nonprogressing HIV-infected children share fundamental immunological features of nonpathogenic SIV infection

artículo científico publicado en 2016

Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization

artículo científico publicado en 2021

Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization

artículo científico publicado en 2022

Omicron infection enhances Delta antibody immunity in vaccinated persons

artículo científico publicado en 2022

Ontogeny-based immunogens for the induction of V2-directed HIV broadly neutralizing antibodies

scientific article published on January 2017

Phenotypic characterization of HIV type 1 isolates from Ghana

artículo científico publicado en 2007

Polyclonal B cell responses to conserved neutralization epitopes in a subset of HIV-1-infected individuals

artículo científico publicado en 2011

Positive Selection at Key Residues in the HIV Envelope Distinguishes Broad and Strain-Specific Plasma Neutralizing Antibodies

article

Potent and broad neutralization of HIV-1 subtype C by plasma antibodies targeting a quaternary epitope including residues in the V2 loop

artículo científico publicado en 2011

Predicted genotypic resistance to the novel entry inhibitor, BMS-378806, among HIV-1 isolates of subtypes A to G.

artículo científico publicado en 2004

Proceedings of the Frontiers of Retrovirology Conference 2016.

artículo científico publicado en 2016

Rapid and Focused Maturation of a VRC01-Class HIV Broadly Neutralizing Antibody Lineage Involves Both Binding and Accommodation of the N276-Glycan

artículo científico publicado en 2019

Relationship of HIV-1 and SIV envelope glycoprotein trimer occupation and neutralization

artículo científico publicado en 2008

SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma

artículo científico publicado en 2021

Sequencing HIV-neutralizing antibody exons and introns reveals detailed aspects of lineage maturation

scientific article published in Nature Communications

Size Doesn't Matter: Shorter Antibody Loops Can Infiltrate HIV's Env Apex Defenses

artículo científico publicado en 2017

Somatic hypermutation to counter a globally rare viral immunotype drove off-track antibodies in the CAP256-VRC26 HIV-1 V2-directed bNAb lineage

artículo científico publicado en 2019

South African HIV-1 subtype C transmitted variants with a specific V2 motif show higher dependence on α4β7 for replication

artículo científico publicado en 2015

Specificity of the autologous neutralizing antibody response

artículo científico publicado en 2009

Structure and Recognition of a Novel HIV-1 gp120-gp41 Interface Antibody that Caused MPER Exposure through Viral Escape.

artículo científico publicado en 2017

Structure of Super-Potent Antibody CAP256-VRC26.25 in Complex with HIV-1 Envelope Reveals a Combined Mode of Trimer-Apex Recognition

scientific article published on 01 April 2020

Structure of an N276-Dependent HIV-1 Neutralizing Antibody Targeting a Rare V5 Glycan Hole Adjacent to the CD4 Binding Site

artículo científico publicado en 2016

Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design

artículo científico publicado en 2016

T cell responses to SARS-CoV-2 spike cross-recognize Omicron

artículo científico publicado en 2022

The c3-v4 region is a major target of autologous neutralizing antibodies in human immunodeficiency virus type 1 subtype C infection

artículo científico publicado en 2007

The neutralization breadth of HIV-1 develops incrementally over four years and is associated with CD4+ T cell decline and high viral load during acute infection

artículo científico publicado en 2011

UCLA1, a synthetic derivative of a gp120 RNA aptamer, inhibits entry of human immunodeficiency virus type 1 subtype C

artículo científico publicado en 2012

V2-Directed Vaccine-like Antibodies from HIV-1 Infection Identify an Additional K169-Binding Light Chain Motif with Broad ADCC Activity

article

Variable Dependence on Glycan Recognition within a Lineage of V1V2-directed HIV Neutralizing Antibodies.

artículo científico publicado en 2014

Viral escape from HIV-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypes

artículo científico publicado en 2013

Viral variants that initiate and drive maturation of V1V2-directed HIV-1 broadly neutralizing antibodies

artículo científico publicado en 2015

Virological features associated with the development of broadly neutralizing antibodies to HIV-1

artículo científico publicado en 2015

Lista de obras de Penny Moore

4E10-resistant variants in a human immunodeficiency virus type 1 subtype C-infected individual with an anti-membrane-proximal external region-neutralizing antibody response

A comparative immunogenicity study of HIV-1 virus-like particles bearing various forms of envelope proteins, particles bearing no envelope and soluble monomeric gp120.

Ability to develop broadly neutralizing HIV-1 antibodies is not restricted by the germline Ig gene repertoire

Antibody specificities associated with neutralization breadth in plasma from human immunodeficiency virus type 1 subtype C-infected blood donors

Assessing the safety and pharmacokinetics of the anti-HIV monoclonal antibody CAP256V2LS alone and in combination with VRC07-523LS and PGT121 in South African women: study protocol for the first-in-human CAPRISA 012B phase I clinical trial

Author Correction: T cell responses to SARS-CoV-2 spike cross-recognize Omicron

Binding of the mannose-specific lectin, griffithsin, to HIV-1 gp120 exposes the CD4-binding site

Broad neutralization of human immunodeficiency virus type 1 mediated by plasma antibodies against the gp41 membrane proximal external region

Broadly neutralizing antibodies targeting the HIV-1 envelope V2 apex confer protection against a clade C SHIV challenge

Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design

Cooperation between Strain-Specific and Broadly Neutralizing Responses Limited Viral Escape and Prolonged the Exposure of the Broadly Neutralizing Epitope

Correction for Anthony et al., "Cooperation between Strain-Specific and Broadly Neutralizing Responses Limited Viral Escape and Prolonged the Exposure of the Broadly Neutralizing Epitope".

Correction: Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization

Development of broadly neutralizing antibodies from autologous neutralizing antibody responses in HIV infection

Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers

Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies

Differences in HIV type 1 neutralization breadth in 2 geographically distinct cohorts in Africa

Effect of HIV Envelope Vaccination on the Subsequent Antibody Response to HIV Infection

Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant

Emergence and phenotypic characterization of the global SARS-CoV-2 C.1.2 lineage

Evidence for both Intermittent and Persistent Compartmentalization of HIV-1 in the Female Genital Tract

Evolution of an HIV glycan-dependent broadly neutralizing antibody epitope through immune escape

Extensive purifying selection acting on synonymous sites in HIV-1 Group M sequences

Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization

Frequency, kinetics and determinants of viable SARS-CoV-2 in bioaerosols from ambulatory COVID-19 patients infected with the Beta, Delta or Omicron variants

Functional and genetic analysis of coreceptor usage by dualtropic HIV-1 subtype C isolates

Genetic characteristics of HIV-1 subtype C envelopes inducing cross-neutralizing antibodies

Genotypic and phenotypic characterization of viral isolates from HIV-1 subtype C-infected children with slow and rapid disease progression

HIV Superinfection Drives De Novo Antibody Responses and Not Neutralization Breadth

HIV broadly neutralizing antibody targets

HIV-1 Subtype C-Infected Children with Exceptional Neutralization Breadth Exhibit Polyclonal Responses Targeting Known Epitopes

High titer HIV-1 V3-specific antibodies with broad reactivity but low neutralizing potency in acute infection and following vaccination

High-Frequency, Functional HIV-Specific T-Follicular Helper and Regulatory Cells Are Present Within Germinal Centers in Children but Not Adults

Identification of broadly neutralizing antibody epitopes in the HIV-1 envelope glycoprotein using evolutionary models

IgG3 enhances neutralization potency and Fc effector function of an HIV V2-specific broadly neutralizing antibody

In vitro generation of HIV type 1 subtype C isolates resistant to enfuvirtide

Inhibition of HIV Env binding to cellular receptors by monoclonal antibody 2G12 as probed by Fc-tagged gp120.

Isolation of a monoclonal antibody that targets the alpha-2 helix of gp120 and represents the initial autologous neutralizing-antibody response in an HIV-1 subtype C-infected individual

Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection

Mannose-rich glycosylation patterns on HIV-1 subtype C gp120 and sensitivity to the lectins, Griffithsin, Cyanovirin-N and Scytovirin

Mechanisms of HIV-1 subtype C resistance to GRFT, CV-N and SVN.

Multiple pathways of escape from HIV broadly cross-neutralizing V2-dependent antibodies

N-linked glycan modifications in gp120 of human immunodeficiency virus type 1 subtype C render partial sensitivity to 2G12 antibody neutralization

Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1.

Neutralization Breadth and Potency of Single-Chain Variable Fragments Derived from Broadly Neutralizing Antibodies Targeting Multiple Epitopes on the HIV-1 Envelope

New Member of the V1V2-Directed CAP256-VRC26 Lineage That Shows Increased Breadth and Exceptional Potency

Nonprogressing HIV-infected children share fundamental immunological features of nonpathogenic SIV infection

Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization

Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization

Omicron infection enhances Delta antibody immunity in vaccinated persons

Ontogeny-based immunogens for the induction of V2-directed HIV broadly neutralizing antibodies

Phenotypic characterization of HIV type 1 isolates from Ghana

Polyclonal B cell responses to conserved neutralization epitopes in a subset of HIV-1-infected individuals

Positive Selection at Key Residues in the HIV Envelope Distinguishes Broad and Strain-Specific Plasma Neutralizing Antibodies

Potent and broad neutralization of HIV-1 subtype C by plasma antibodies targeting a quaternary epitope including residues in the V2 loop

Predicted genotypic resistance to the novel entry inhibitor, BMS-378806, among HIV-1 isolates of subtypes A to G.

Proceedings of the Frontiers of Retrovirology Conference 2016.

Rapid and Focused Maturation of a VRC01-Class HIV Broadly Neutralizing Antibody Lineage Involves Both Binding and Accommodation of the N276-Glycan

Relationship of HIV-1 and SIV envelope glycoprotein trimer occupation and neutralization

SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma

Sequencing HIV-neutralizing antibody exons and introns reveals detailed aspects of lineage maturation

Size Doesn't Matter: Shorter Antibody Loops Can Infiltrate HIV's Env Apex Defenses

Somatic hypermutation to counter a globally rare viral immunotype drove off-track antibodies in the CAP256-VRC26 HIV-1 V2-directed bNAb lineage

South African HIV-1 subtype C transmitted variants with a specific V2 motif show higher dependence on α4β7 for replication

Specificity of the autologous neutralizing antibody response

Structure and Recognition of a Novel HIV-1 gp120-gp41 Interface Antibody that Caused MPER Exposure through Viral Escape.

Structure of Super-Potent Antibody CAP256-VRC26.25 in Complex with HIV-1 Envelope Reveals a Combined Mode of Trimer-Apex Recognition

Structure of an N276-Dependent HIV-1 Neutralizing Antibody Targeting a Rare V5 Glycan Hole Adjacent to the CD4 Binding Site

Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design

T cell responses to SARS-CoV-2 spike cross-recognize Omicron

The c3-v4 region is a major target of autologous neutralizing antibodies in human immunodeficiency virus type 1 subtype C infection

The neutralization breadth of HIV-1 develops incrementally over four years and is associated with CD4+ T cell decline and high viral load during acute infection

UCLA1, a synthetic derivative of a gp120 RNA aptamer, inhibits entry of human immunodeficiency virus type 1 subtype C

V2-Directed Vaccine-like Antibodies from HIV-1 Infection Identify an Additional K169-Binding Light Chain Motif with Broad ADCC Activity

Variable Dependence on Glycan Recognition within a Lineage of V1V2-directed HIV Neutralizing Antibodies.

Viral escape from HIV-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypes

Viral variants that initiate and drive maturation of V1V2-directed HIV-1 broadly neutralizing antibodies

Virological features associated with the development of broadly neutralizing antibodies to HIV-1